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Human immunodeficiency virus type 1 (HIV-1) proteins are expressed from both intron-containing and completely spliced
RNAs. Rev, an HIV-1 regulatory protein, is necessary for the expression of intron-containing RNAs. The effect of Rev on the
subcellular localization of intron-containing HIV-1 RNA was examined by in situ RNA hybridization. In the presence of Rev,
intron-containing HIV-1 RNA accumulated at the nuclear membrane and within the cytoplasm of transfected cells. In the
absence of Rev, intron-containing HIV-1 RNA accumulated within the nucleus. In ;20% of the cells transfected in the absence
of Rev, intron-containing HIV-1 RNA was also found in the cytoplasm. Differences in the subcytoplasmic localization of
intron-containing HIV-1 RNA in the presence and absence of Rev were not observed using in situ RNA hybridization. To
determine the effect of Rev on RNA localization within the cytoplasm, an extensive fractionation protocol involving both
hypotonic and detergent lysis was used. In the presence of Rev, 40.9 6 4.6% of the cytoplasmic intron-containing HIV-1 RNA
was released by hypotonic lysis. A similar fractionation profile was seen for several other translated viral and cellular RNAs.
However, in the absence of Rev, only 16.5 6 5.1% of the cytoplasmic intron-containing HIV-1 RNA was released on hypotonic
lysis (P , 0.005). Thus the cytoplasmic fractionation pattern of this RNA was altered in the absence of Rev. © 1999 Academic Press
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Human immunodeficiency virus type 1 (HIV-1) Rev is a
9-kDa regulatory protein that binds to HIV-1 RNAs at the
RE (Rev response element) (Daly et al., 1989; Feinberg
t al., 1986; Felber et al., 1989; Olsen et al., 1990a, 1990b;
erkins et al., 1989; Sodroski et al., 1986; Zapp and
reen, 1989). Three classes of RNA are expressed by
IV-1: unspliced, partially spliced, and fully spliced (Arya
t al., 1985; Muesing et al., 1987). The RRE is located
ithin unspliced and partially spliced RNAs (Cochrane et
l., 1990, 1990; Daly et al., 1989; Green, 1989; Heaphy et
l., 1990; Malim et al., 1990). These intron-containing
NAs of HIV-1 contain cis-acting repressor sequences
CRS) that negatively regulate HIV-1 expression by an
nknown mechanism (for review, see Dayton, 1996). The
xpression of these CRS-containing RNAs is dependent
n Rev (Felber et al., 1989; Hadzopoulou et al., 1989;
ammarskjold et al., 1989; Malim et al., 1989a, 1989b,
989c; Rosen et al., 1988). Many studies have shown that
n the presence of Rev, cytoplasmic accumulation of
RE-containing RNAs is increased (Emerman et al., 1989;
elber et al., 1989; Fischer et al., 1995, 1994; Hammar-
kjold et al., 1989; Malim et al., 1989a, 1989b, 1989c).
1 To whom reprint requests should be addressed at Basic Sciences
uilding, Room 201, 171 Ashley Avenue. Fax: (843) 792-2464. E-mail:Mchmidtm@musc.edu.
237iminished splicing of intron-containing HIV-1 RNA in the
resence of Rev has also been reported (Arrigo and
hen, 1991; Emerman et al., 1989; Favaro and Arrigo,
997; Favaro et al., 1998; Felber et al., 1989; Fischer et al.,
995, 1994; Hammarskjold et al., 1989; Malim et al.,
989a, 1989b, 1989c). Once in the cytoplasm, Rev is
mportant for the translation and stability of intron-con-
aining HIV-1 RNAs (Arrigo and Chen, 1991; Cochrane et
l., 1991; D’Agostino et al., 1992; Felber et al., 1989;
awrence et al., 1991). The unique activities of Rev co-
rdinate the expression of intron-containing HIV-1 RNAs
s the structural proteins of HIV-1 (Dayton, 1996).
The Rev protein consists of two functional domains: a
ighly basic amino-terminal domain and a carboxyl-ter-
inal domain. The amino-terminal domain is responsible
or binding to the RRE, oligomerization, and nuclear nu-
leolar localization (Garrett and Cullen, 1992; Malim et
l., 1989a). The carboxyl end of the molecule contains a
eucine-rich stretch of amino acids that acts as a nuclear
xport signal (NES). The cellular export pathways for U
nRNA and 5S rRNA may be used for the Rev NES to
xport HIV-1 RNAs (Fischer et al., 1995, 1994; Wen et al.,
995).
The function of Rev as a posttranscriptional transactiva-
or of intron-containing HIV-1 RNAs has been studied in a
ariety of human and nonhuman cell types, including fibro-
lastic, epithelial, and lymphoid cell lines (Berthold and
aldarelli, 1996; Borg et al., 1997; D’Agostino et al., 1992;
0042-6822/99 $30.00
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238 FAVARO ET AL.avaro and Arrigo, 1997; Malim et al., 1989a, 1989b, 1989c).
n some cell lines, transactivation of HIV-1 RNAs by coex-
ression of Rev has not been observed (Neumann et al.,
995), suggesting the absence of important host factors
equired for Rev-induced activity. In other cell lines, Rev has
een shown to be an essential component for the activation
f structural genes of HIV-1. In many cases, Rev binds to
IV-1 RNA and facilitates its shuttling to the cytoplasm (for
eview, see Emerman and Malim, 1998). In a study by
erthold and Maldarelli (1996), in situ RNA hybridization
as used to examine the localization of unspliced, proviral
IV-1 RNA in HeLa cells. Cytoplasmic accumulation in
hese cells was only observed in the presence of Rev
interestingly, in other cell systems, CRS-containing HIV-1
NAs accumulate, to a degree, in the cytoplasm in the
bsence of Rev but are not translated unless Rev is present
Arrigo and Chen, 1991; Cochrane et al., 1991; D’Agostino et
l., 1992; Favaro and Arrigo, 1997; Huang and Carmichael,
996; Kimura et al., 1996; Lawrence et al., 1991). Previous
tudies have examined the translational effects of Rev us-
ng a human B cell line. These studies revealed that Rev
acilitates interaction of the translational machinery with
ntron-containing HIV-1 RNA (Arrigo and Chen, 1991; Camp-
ell et al., 1994); however, the mechanism for this Rev-
ependent interaction is unknown. In this report, in situ
NA hybridization and a novel biochemical fractionation
rotocol were used to investigate the role of Rev on the
ytoplasmic localization and translation of the RNA of HIV-1.
RESULTS
ocalization of intron-containing HIV-1 RNA in the
resence of Rev
Previous subcellular fractionation studies have re-
ealed that intron-containing HIV-1 RNA is found in the
ytoplasmic fractions in both the presence and absence
f Rev (Arrigo and Chen, 1991; Favaro and Arrigo, 1997).
owever, translation of this RNA is observed only in the
resence of Rev (Arrigo and Chen, 1991; Campbell et al.,
994). In this report, a connection between the subcyto-
lasmic localization and translation of an intron-contain-
ng HIV-1 RNA was explored. The localization of intron-
ontaining HIV-1 RNA was first examined in the pres-
nce of Rev by in situ RNA hybridization. Subgenomic tat
onstructs of HIV-1 (formerly named subgenomic env
onstructs; Favaro and Arrigo, 1997) express two classes
f RNA: an intron-containing, unspliced RNA, and a fully
pliced RNA (Fig. 1). Unspliced tat probes specific for
ntron-containing HIV-1 RNA were biotinylated and used
o perform in situ RNA hybridization on fixed cells. These
robes will hybridize only to sequences within the re-
aining intron of the unspliced RNA (Fig. 1). Streptavidin
exas Red was used to detect the intron-containing
IV-1 RNA signal. The cells were optically sectioned with
aser scanning confocal microscopy.
The staining patterns observed in cells transfected aith the wild-type Rev construct (CSF BSSH) are shown
n Figure 2. The two images on the left represent the
ransmission images of each cell. The nucleus is visible
s the granular area in the middle of the cell, surrounded
y a raised nuclear membrane. The Texas Red signal,
epresenting intron-containing HIV-1 RNA, is shown on
he right. Diffuse staining is observed in the nucleus,
xcluding the nucleolus. In addition, a remarkable ring of
taining is seen around the nucleus. Compared with the
ransmission image, this ring localized at the nuclear
embrane. In addition, a high degree of intron-contain-
ng HIV-1 RNA signal localized in the cytoplasm. This
attern was observed in .400 cells from three different
ransfections of the wild-type Rev construct.
ocalization of intron-containing HIV-1 RNA in
bsence of Rev
The cytoplasmic localization of intron-containing RNA
f HIV-1 in the absence of Rev was determined by ex-
FIG. 1. Subgenomic tat HIV-1 constructs. The open reading frames of
he HIV-1 genome (top) are indicated. The subgenomic tat constructs
middle) were created by deleting 5084 bp from the proviral construct
YKJRCSF/EBV2. The open boxes represent the remaining sequences;
he solid lines indicate deletions; CSF BSSH contains the wild-type rev
ene; the DSAL BSSH construct expresses a truncated, nonfunctional
ev protein; and the X indicates a frameshift mutation within the rev
ene. The two classes of RNA expressed from these constructs are
hown on the bottom. The unspliced HIV-1 RNA was detected using
wo probes (indicated by black boxes): unspliced tat probe 1 (hybrid-
zes between sequences 6317-7744) and unspliced tat probe 2 (hybrid-
zes between sequences 7721-7993). The dotted line indicates se-
uences that have been spliced out.mining cells transfected with a plasmid containing the
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239LOCALIZATION AND EXPRESSION OF HIV-1 RNAubgenomic tat construct with a frameshift mutation in
he wild-type Rev gene at nucleotide 8482. This new
onstruct, DSAL BSSH, expressed a truncated, nonfunc-
ional Rev protein (Favaro and Arrigo, 1997). Unspliced
FIG. 2. Distribution of intron-containing HIV-1 RNA in cells transfecte
ixed onto slides, and the tat probes specific for unspliced HIV-1 RNA we
ignal was detected with streptavidin Texas Red. A laser scanning con
nd in situ signals of two representative cells are shown. Bar, 30 mm.at probes (Fig. 1) were used to detect intron-containing oIV-1 RNA by in situ RNA hybridization. The staining
atterns observed in these cells are shown in Figure 3.
n Fig. 3A, all of the detectable intron-containing HIV-1
NA localized in the nucleoplasm, excluding the nucle-
the wild-type Rev construct. The transfected cells were cytospun and
d to perform in situ RNA hybridization. The intron-containing HIV-1 RNA
icroscope was used to optically section each cell. The transmissiond with
re use
focal mlus. Overlap of the unspliced RNA signal and the nu-
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240 FAVARO ET AL.lear membrane was not observed. A second staining
attern was also observed in ;20% of the cells trans-
ected with the mutant Rev construct (Fig. 3B). In these
ells, the intron-containing HIV-1 RNA signal was ob-
erved in both the nucleus and the cytoplasm. Because
luorescent in situ RNA hybridization is relatively insen-
FIG. 3. Distribution of intron-containing HIV-1 RNA in cells transfected
nto slides, and the tat probes specific for unspliced HIV-1 RNA were
ignal was detected with streptavidin Texas Red. A laser scanning con
nd in situ signals of two representative cells are shown. (A) Cell with in
ith both nuclear and cytoplasmic intron-containing HIV-1 RNA signalitive for the detection of cytoplasmic HIV-1 RNA iBerthold and Maldarelli, 1996; Favaro et al., 1998), this
pproximation likely underestimates the number of cells
ith cytoplasmic accumulation of intron-containing HIV-1
NA. These two staining patterns were observed in
400 cells from three different transfections with the
utant Rev construct. Additional examples highlighting
e mutant Rev construct. The transfected cells were cytospun and fixed
o perform in situ RNA hybridization. The intron-containing HIV-1 RNA
icroscope was used to optically section each cell. The transmission
ntaining HIV-1 RNA signal completely localized to the nucleus. (B) Cell
0 mm.with th
used t
focal m
tron-contron-containing HIV-1 RNA staining patterns, both in
t
F
f
R
c
a
s
s
241LOCALIZATION AND EXPRESSION OF HIV-1 RNAhe presence and absence of Rev, are presented in
igure 4.
To address whether cellular damage was a causative
FIG. 4. Distribution of intron-containing HIV-1 RNA in cells transfected
ignal was examined by in situ RNA hybridization as described for Figs
hown. Bars, 30 mm.actor for the accumulation of intron-containing HIV-1 aNA signal in the cytoplasm, localization of both intron-
ontaining HIV-1 RNA and hnRNP A1 (protein) were ex-
mined. Previous studies have shown that hnRNP A1 is
ther the wild-type or mutant Rev construct. Intron-containing HIV-1 RNA
3. Both the transmission and intron-containing HIV-1 RNA signals arewith ei
. 2 andn RNA binding protein that diffusely stains the nucleus
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242 FAVARO ET AL.non-nucleolar) of interphase cells by immunofluores-
ence (Dreyfuss et al., 1993). The hnRNP A1 signal is
ound in the cytoplasm when the nuclear membrane is
egraded (e.g., during cell division) or when transcription
s inhibited (Pinol-Roma and Dreyfuss, 1991). Thus sub-
ellular localization of hnRNP A1 can be used as an
ndicator of nuclear integrity and the transcriptional sta-
us of the cell. Cells expressing the mutant Rev construct
ere costained for unspliced HIV-1 RNA and hnRNP A1.
ven in cells with cytoplasmic, intron-containing HIV-1
NA signal, hnRNP A1 was localized entirely in the
ucleus (Fig 5).
To ensure that the in situ signal was derived from RNA,
ells transfected with the wild-type or mutant Rev con-
tructs were treated with 0.2 N NaOH before being ex-
osed to the probe used in situ. Treatment with 0.2 N
aOH will degrade the RNA while leaving the DNA intact
Parish, 1972). Specific RNA signal was not observed in
ells transfected with either construct (data not shown).
s a control for HIV-1 specific signal, mock transfected
ells were similarly examined by in situ and laser scan-
ing confocal microscopy; again, no specific signal was
bserved (data not shown).
ranslation of HIV-1 RNAs
To confirm that translation of unspliced HIV-1 RNA was
ev dependent, radiolabeling studies were performed
sing S35cys. The measurement of the incorporation of
35cys into new protein revealed a 27-fold increase in the
resence of Rev (data not shown). As previously reported
n human lymphocytic cell lines, only a 3-fold increase in
he cytoplasmic level of intron-containing HIV-1 RNA was
bserved in the presence of Rev (unpublished data and
avaro and Arrigo, 1997). Thus the 27-fold increase in
ranslation in the presence of Rev cannot be simply
xplained by an increase in the level of cytoplasmic RNA.
ubcellular fractionation of HIV-1 and cellular RNAs
To characterize differences in the cytoplasmic, intron-
ontaining HIV-1 RNA in the presence and absence of
ev, the fractionation patterns of both viral and cellular
RNAs were compared. Previous studies on Rev func-
ion in human lymphocytic cell lines used detergent lysis
o separate the nuclear and cytoplasmic fractions (Arrigo
nd Chen, 1991; Favaro and Arrigo, 1997; Malim and
ullen, 1993). To more extensively separate HIV-1 RNAs
ithin the cytoplasm, cells transfected with the wild-type
r mutant Rev constructs were fractionated by separately
sing hypotonic and detergent lysis buffers. The cells
ere initially lysed by hypotonic swelling buffer (HSB),
ithout detergent, for 10 min and then centrifuged. The
upernatant was designated fraction 1. Next, the pellet
as washed using 0.05% Nonidet P-40 (NP-40) lysis
uffer (fraction 2) and 0.65% NP-40 lysis buffer (fraction 3)
s previously described (Favaro and Arrigo, 1997). The ninal pellet was resuspended in 0.65% NP-40 and desig-
ated the nuclear fraction. RNA was prepared from the
ractions, and quantitative RT-PCR was performed using
rimers specific for viral and cellular RNAs. Experiments
ere performed in triplicate for both wild-type and mu-
ant Rev constructs, and the results were quantified and
veraged. To determine the accuracy and reproducibility
f this protocol, the percentages of HIV-1 and cellular
NAs in the nuclear and combined cytoplasmic fractions
1-3) were determined (Fig. 6). Three different cellular
NAs were used as controls. Because the majority of
ellular RNAs are completely spliced before export to the
ytoplasm (Green, 1986; Padgett et al., 1986), unspliced
ellular RNAs can serve as a control for leakage of
uclear RNAs if they are found in the cytoplasmic frac-
ions. Previous studies have used b-actin unspliced RNA
or this purpose (Favaro and Arrigo, 1997). In this report,
8-86% of b-actin unspliced RNA was found in the nu-
lear fraction (Fig. 6). Because splicing and export of
ellular RNAs are closely linked, spliced cellular RNAs
ocalize predominantly to the cytoplasm (Green, 1986;
adgett et al., 1986). Additionally, 91-92% of spliced
APDH RNA and 85-88% of spliced MHC RNA were
ound in the cytoplasmic fractions (Fig. 6). The presence
f wild-type or mutant Rev did not have a significant
ffect on the fractionation of these cellular RNAs. The
ffect of Rev on the nuclear/cytoplasmic distribution of
IV-1 RNAs was also examined. Similar to the cellular
pliced RNAs, the majority of fully spliced HIV-1 RNA
80-87%) was found in the cytoplasmic fractions in both
he presence and absence of Rev. Additionally, a large
ercentage of intron-containing HIV-1 RNA was ob-
erved in the cytoplasmic fractions in both the presence
86%) and absence (61%) of Rev. In contrast, only 14-22%
f the control for nuclear leakage (b-actin unspliced
NA) was found in the cytoplasmic fractions. A similar
uclear/cytoplasmic fractionation profile has been previ-
usly observed for HIV-1 RNAs by detergent-mediated
ysis (Favaro and Arrigo, 1997).
Thus far, we have demonstrated that intron-containing
IV-1 RNA accumulates within the cytoplasm both in the
resence and, to a slightly lesser extent, the absence of
ev. However, without Rev, almost no translation of this
NA was detected. Thus conditions within the cytoplasm
ay be inhibiting the interactions of intron-containing
IV-1 RNA with the translational machinery in the ab-
ence of Rev. To further characterize the effect of Rev in
he cytoplasm, the subcytoplasmic fractionation pattern
f intron-containing HIV-1 RNA was compared with trans-
ated cellular and HIV-1 RNAs. Excluding the data for the
uclear fraction, the average percent of each RNA in
ach cytoplasmic fraction (fractions 1-3) was calculated
nd plotted (Fig. 7). GAPDH mRNA has previously been
hown to fractionate with free polysomes and is there-
ore expected to be translated on free ribosomes (Johan-
essen et al., 1995). Lysis of the cells in hypotonic buffer,
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243LOCALIZATION AND EXPRESSION OF HIV-1 RNAithout detergent (fraction 1), resulted in the release of a
arge percentage (53-54%) of the cytoplasmic GAPDH
FIG. 5. Distribution of intron-containing HIV-1 RNA and hnRNP A1 in
ytospun and fixed onto slides, and the tat probes specific for un
ntron-containing HIV-1 RNA signal was detected with streptavidin Texas
nRNP A1 signal was detected by a secondary antibody conjugated to
middle), and hnRNP A1 protein signal (bottom) are shown. Each imag
icroscope. Bar, 30 mm.pliced RNA. The remainder of this RNA was released on the addition of NP-40 detergent buffer. MHC class 1 is a
embrane protein that, unlike GAPDH, is expected to be
transfected with the mutant Rev construct. The transfected cells were
HIV-1 RNA were used to perform in situ RNA hybridization. The
nti-hnRNP A1 antibody was used to perform immunofluorescence. The
A transmission image (top), intron-containing HIV-1 RNA signal image
sents the same optical section taken with a laser scanning confocala cell
spliced
Red. A
FITC.
e repreranslated on membrane-bound ribosomes. To deter-
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244 FAVARO ET AL.ine whether differences in RNA localization could af-
ect the cytoplasmic fractionation pattern, MHC class I
pliced RNA was examined. Only 5-6% of cytoplasmic
HC I spliced RNA was released on hypotonic lysis
fraction 1). Almost all of this RNA (94-95%) was released
n the addition of NP-40 detergent buffer (fractions 2 and
). Thus differences in the solubility of GAPDH and MHC
pliced mRNAs can be discriminated within the cytoplas-
ic fractions.
The effect of Rev on the subcytoplasmic fractionation
f HIV-1 RNAs was also examined. The intron-containing
nd fully spliced HIV-1 RNAs express different forms of
he viral protein Tat. This protein is a soluble transcrip-
ion factor that, like GAPDH, should be translated on free
ibosomes. As expected, a large percentage of the fully
pliced HIV-1 RNA (40-44%) was released by hypotonic
ysis in both the presence and absence of Rev. In the
FIG. 6. Nuclear/cytoplasmic fractionation of HIV-1 and cellular RNAs
n the presence and absence of Rev. Cells transfected with the wild-
ype or mutant Rev construct were fractionated using hypotonic lysis
nd increasing concentrations of NP-40 detergent. RNA was prepared
rom each cytoplasmic fraction and the nuclear fraction; quantitative
T-PCR was performed for the indicated RNAs. PCR products were
eparated on a 6% polyacrylamide gel. Individual bands were quanti-
ied, and the percentages of RNA in the combined cytoplasmic frac-
ions (1-3) and nuclear fraction were calculated, averaged for three
ransfections, and plotted. The error bars represent standard deviation.resence of Rev, intron-containing HIV-1 RNA had a dimilar fractionation profile to that of fully spliced HIV-1
NA. Hypotonic lysis (fraction 1) resulted in the release
f a large proportion (40.9 6 4.6%) of the cytoplasmic
ntron-containing HIV-1 RNA. In contrast, in the absence
f Rev, the percentage of the cytoplasmic intron-contain-
ng HIV-1 RNA released by hypotonic lysis decreased to
6.5 6 5.1%. The difference in the percentage of intron-
ontaining HIV-1 RNA released in fraction 1, in the pres-
nce and absence of Rev, was statistically significant
ver three separate experiments (P , 0.005). Only when
etergent was added to the fractionation buffer (fraction
) was a large proportion (51.8 6 4.3%) of the intron-
ontaining HIV-1 RNA released from the cytoplasm in the
bsence of Rev. Thus untranslated intron-containing
IV-1 RNA (without Rev) had a different cytoplasmic
ractionation pattern than translated HIV-1 RNA.
DISCUSSION
In this report, the localization, translation, and fraction-
tion of intron-containing HIV-1 RNA were examined. A
revious study examining the distribution of unspliced
IV-1 RNA by electron microscopy reported a punctate
istribution pattern along the nuclear membrane in the
resence of Rev (Romanov et al., 1997). In this study,
ntron containing HIV-1 RNA surrounded almost the en-
ire nucleus in the presence of Rev. A low level of diffuse
ntron-containing HIV-1 RNA signal was also observed in
he nucleoplasm. The previously described NES (Fischer
t al., 1995, 1994; Wen et al., 1995) located within the Rev
ctivation domain may interact with export factors in the
ucleoplasm and expedite transport to the nuclear mem-
rane. The export factors hRIP/Rab, and exportin 1
CRM1) have been shown to interact with the Rev NES
nd may shuttle Rev and intron-containing HIV-1 RNA to
he nuclear pore complex (Bogerd et al., 1995; Fornerod
t al., 1997; Fritz et al., 1995). High levels of expression,
ombined with the facilitated movement of intron-con-
aining HIV-1 RNA through the nucleoplasm, may gener-
te a “bottleneck” at the nuclear pore complex in the
resence of Rev. All of these results suggest that move-
ent across the nuclear membrane is the rate-limiting
tep in Rev-mediated export.
In addition to the accumulation of HIV-1 RNA at the
uclear membrane, this study investigated the effects of
ev on the cytoplasmic accumulation of HIV-1 RNA. In
he presence of Rev, intron-containing HIV-1 RNA accu-
ulated in the cytoplasm of all transfected cells, as
bserved with laser scanning confocal microscopy. Cy-
oplasmic accumulation was also seen in ;20% of the
ells transfected with the mutant Rev construct. The
ntegrity of the nuclei of cells containing cytoplasmic,
ntron-containing HIV-1 RNA signal in the absence of Rev
as examined. The nuclear staining patterns and the
uclear morphology were not visibly different in cells
isplaying a cytoplasmic signal. The nuclear localization
o
m
r
a
m
t
c
R
d
H
o
s
R
P
s
b
t
1
t
e
e
t
t
s
t
i
c
n
R
R
t
t
o
a
R
c
f
R
f . The e
245LOCALIZATION AND EXPRESSION OF HIV-1 RNAf hnRNP A1 signal also suggested that the nuclear
embrane was intact and that transcription was occur-
ing within the cell. Regarding the subcellular fraction-
tion data, only a low percentage of unspliced b-actin
essage (a control for nuclear leakage) was observed in
he cytoplasmic fractions. Each of these controls indi-
ated that the accumulation of intron-containing HIV-1
NA within the cytoplasm, in the absence of Rev, was not
ue to nuclear leakage.
The effect of Rev on the translation of intron containing
IV-1 RNA was examined. A 27-fold increase in the level
f protein expressed in the presence of Rev was ob-
erved. The concentration of intron-containing HIV-1
NA in the cytoplasm, as measured by quantitative RT-
CR, increased only 3-fold in the presence Rev (data not
hown and Favaro and Arrigo, 1997). Similar results have
een reported when examining the effect of Rev on the
FIG. 7. Cytoplasmic fractionation of HIV-1 and cellular RNAs in the p
ev construct were initially lysed in HSB for 10 min. The cells were c
ytoplasmic components were stripped away using 0.05% NP-40 lysis bu
raction were not used for this figure. RNA was prepared from each cy
NAs. PCR products were separated on a 6% polyacrylamide gel. Indiv
raction was calculated, averaged for three transfections, and graphedranslation of RNA in other systems (Arrigo and Chen, a991; D’Agostino et al., 1992; Lawrence et al., 1991). How,
hen, is this cytoplasmic HIV-1 RNA different in the pres-
nce and absence of Rev? To address this question, the
ffect of Rev on the subcytoplasmic fractionation of in-
ron-containing HIV-1 RNA was examined (Fig. 7). Ini-
ially, transfected cells were lysed in HSB. On micro-
copic examination, the majority of the cells were unable
o exclude trypan blue, but the subcellular structure was
ntact. Thus only the most soluble components of the
ytoplasm were released into the supernatant (desig-
ated fraction 1). Large proportions of the fully spliced HIV-1
NA, GAPDH spliced mRNA, and intron-containing HIV-1
NA (in the presence of Rev) were found in fraction 1. In
he absence of Rev, however, a significant decrease in
he percentage of intron-containing HIV-1 RNA released
n hypotonic lysis was observed, whereas the fraction-
tion of other RNAs did not change. Thus Rev served as
e and absence of Rev. Cells transfected with the wild-type or mutant
ed, and the supernatant was designated fraction 1. The less-soluble
ction 2) and 0.65% NP-40 lysis buffer (fraction 3). Data from the nuclear
ic fraction, and quantitative RT-PCR was performed for the indicated
ands were quantified, and the percentage of cytoplasmic RNA in each
rror bars represent standard deviation.resenc
entrifug
ffer (fra
toplasm
idual bpositive effector molecule in the translation of intron-
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246 FAVARO ET AL.ontaining HIV-1 RNA while altering the cytoplasmic frac-
ionation profile of this RNA.
An association of the translational machinery with
ntron-containing HIV-1 RNA in the presence of Rev might
ccount for the differences in the subcellular fraction-
tion pattern of this RNA. Rev has been shown to pro-
ote the association of polysomes and PABP-1 with
ytoplasmic intron-containing HIV-1 RNA (Arrigo and
hen, 1991; Campbell et al., 1994). In addition, other
roups have shown that the translation factor eIF-5A
ssociates with the Rev protein (Bevec et al., 1996; Ruhl
t al., 1993). A study by Kimura et al., 1996 sheds light on
ow the translational status of HIV-1 RNA may be linked
o subcytoplasmic localization of the RNA. In HeLa cells,
nspliced HIV-1 RNA was shown to colocalize with the
-actin cytoskeleton only in the presence of Rev (Kimura
t al., 1996). Another study has shown that polysomes
nd translational elongation factor EF-1a localize to actin
ilament intersections in the cytoplasm (Bassell et al.,
994). Thus Rev may promote the localization of intron-
ontaining HIV-1 RNA with cytoplasmic constituents as-
ociated with the translational machinery, leading to the
bserved difference in fractionation.
The subcytoplasmic localization of HIV-1 RNA may
e important for translation of viral proteins. By dem-
nstrating that accumulation of intron-containing
IV-1 RNA in the hypotonic lysis fraction is inhibited in
he absence of Rev, this study has contributed to the
nderstanding of Rev activity in the cytoplasm. Higher
esolution microscopy and more extensive subcellular
ractionation will be required to determine which cel-
ular factors might be important for the translational
tatus of HIV-1 RNA.
MATERIALS AND METHODS
onstructs, transfections, and cell culture
The human 729 B cell line was maintained in
scove’s medium supplemented with 10% FCS, glu-
amine, penicillin, and streptomycin. The B cells (2 3
07) were electroporated with 100 mg of the sub-
enomic tat HIV-1 constructs CSF BSSH (wild-type
ev) or DSAL BSSH (mutant Rev) as described previ-
usly (Favaro and Arrigo, 1997). These constructs
ere previously referred to as the subgenomic env
onstructs (Favaro and Arrigo, 1997). DSAL BSSH con-
truct contains a frameshift mutation at nucleotide
482, thereby expressing a truncated, nonfunctional
ev protein. Each of these constructs is under the
ontrol of an HIV-1 LTR promoter.
n situ RNA hybridization and laser scanning
onfocal microscopy
Harvested cells were washed in PBS and cytospun
nto glass slides coated with 1% BSA in PBS (McGahon ht al., 1995). The cells were fixed with Streck tissue
ixative for 10 min, washed, and stored in 70% ethanol.
treck tissue fixative contains diazolidinyl urea, 2-bromo-
-nitropropane-1, 3-diol, zinc sulfate, and sodium citrate.
his cytospin-and-fixation protocol was most ideal for
reserving cellular architecture and size while still allow-
ng for high levels of in situ signal. The remaining in situ
NA hybridization protocol was adopted from published
tudies performed by Berthold and Maldarelli (1996) and
ohnson et al. (1991). The unspliced tat probe 1 is a DNA
robe made by PCR amplification of the sequences from
317-7744 within pYKJRCSF. The unspliced tat probe 2
formerly known as the RRE probe) was made by PCR
mplification of the sequences within the RRE of the
roviral HIV-1 construct PNL4-3 (Berthold and Maldarelli,
996). Both of these probes will hybridize only within the
ntron of the unspliced tat RNA. Biotin was incorporated
nto the fragments by nick translation using the BioNick
abeling System (GIBCO BRL). The nick-translated prod-
cts were precipitated with ethanol and resuspended in
ormamide, 1 mg/ml yeast tRNA, and 5 mg/ml boiled,
heared salmon sperm DNA. The probe was mixed 1:1
ith hybridization buffer [203 SSC (3 M sodium chloride
nd 0.3 M sodium citrate), 2% BSA-nuclease free (Boehr-
nger Mannheim), 2 mM vanadyl riboside complexes
GIBCO BRL), 50% dextran sulfate (1:1:1:2)], and 15 ml of
he mixture was spotted onto the cells and incubated
vernight in a humidified chamber at 37°C. Slides were
hen sequentially washed in 23 SSC, 50% formamide,
3 SSC, and 13 SSC and then incubated at 37°C in a
umidified chamber with Texas Red-conjugated strepta-
idin (GIBCO BRL) diluted 1:250 in 43 SSC. The slides
ere washed with 43 SSC, and a coverslip was applied
Berthold and Maldarelli, 1996; Johnson et al., 1991). The
ells were optically sectioned using a laser scanning
onfocal microscope (BioRad or Zeiss LSM4) equipped
ith a krypton-argon laser. The transmission images
ere detected using laser excitation wavelengths of 488,
68, and 647 nm. The intron-containing HIV-1 RNA Texas
ed signal in some cells were examined using an exci-
ation wavelength of 568 nm and an emission of 605 nm.
ther samples were examined with a Zeiss LSM4 con-
ocal microscope using a 568-nm excitation wavelength
nd a 590-nm long-pass filter to visualize Texas Red. To
onfirm that the observed signal was specific for RNA,
ells transfected with the wild-type or mutant Rev con-
tructs were treated with 0.2 N NaOH in 70% ethanol for
0 min (Johnson et al., 1991), and in situ RNA hybridiza-
ion was performed. The cells were examined using
aser scanning confocal microscopy (BioRad) as de-
cribed above.
n situ RNA hybridization and immunofluorescence
Unspliced tat probe 1 was used to perform in situ RNA
ybridization on cells transfected with the mutant Rev
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247LOCALIZATION AND EXPRESSION OF HIV-1 RNAonstruct. After the last 43 SSC wash, the cells were
overed with 50 ml of anti-hnRNP A1 antiserum (1:1000
ilution of 9H10 mouse ascites hnRNP A1 antibody; gift
f Dr. Gideon Dreyfuss) and incubated at 37°C. The cells
ere washed and then incubated with a 1:20 dilution of
ITC-conjugated secondary antibody to mouse IgG (no
ross-reaction to human IgG) (ICN) at 37°C. The cells
ere examined by laser scanning confocal microscopy
s described above. The Texas Red channel was used to
etect the intron-containing HIV-1 RNA signal, and the
nRNP A1 FITC signal was detected using an excitation
avelength of 488 nm and an emission of 522 nm.
adiolabeled immunoprecipitation
Human 729 B cells were transfected with CSF BSSH,
SAL BSSH, or pGEM1 (Promega) as a control, and
4-16 h later, the cells were pulsed for 6 h with 35S
abeled L-cysteine (NEN). The cells were then lysed in 2.0
l of RIPA buffer solution (Arrigo et al., 1989), centrifuged
t 100,000g for 1 h, and then precleared with protein G.
his precleared supernatant was then added to an anti-
at antibody–protein G mixture (final antibody dilution,
:1125) and incubated overnight at 4°C. The polyclonal
IV-1BH10 Tat antiserum (NIH Reference and Reagent
rogram, Toth et al., 1995) is specific for the first 61
mino acids of the HIV-1 Tat. The immunoprecipitate was
hen electrophoresed on a 15% acrylamide gel, fixed
vernight, enhanced with 1 M sodium salicylate for 1 h,
nd dried, and the radioactive signal was detected by
utoradiography. The bands were quantified using NIH
mage version 1.62b4.
NA fractionation and analysis
The B cells were transfected with wild-type or mutant
ev constructs, and 14-16 h after transfection, the cells
ere harvested. To further characterize intron-containing
IV-1 RNA, an extensive subcytoplasmic fractionation
as developed. After two washes with PBS, the cells
ere resuspended in HSB (10 mM NaCl, 1.5 mM MgCl2,
0 mM Tris, pH 7.4). The resuspended cells were then
laced on ice for 10 min. The cells were centrifuged at
00g for 1 min. The supernatant was collected and re-
erred to as fraction 1. The pellet was then washed in
SB, resuspended in 0.05% NP-40 lysis buffer (Malim
nd Cullen, 1993), and immediately centrifuged at 900g
or 1 min. The supernatant was collected and referred to
s fraction 2. The remaining pellet was resuspended in
.65% NP-40 lysis buffer (Arrigo et al., 1989) and imme-
iately centrifuged at 900g for 1 min. The supernatant
as collected and referred to as fraction 3. The final
ellet was resuspended in 0.65% NP-40 lysis buffer and
esignated the nuclear fraction. The RNA was prepared
rom each of the fractions, and quantitative RT-PCR was
erformed as previously outlined (Arrigo et al., 1989).
nspliced and spliced RNAs produced by CSF BSSH and BSAL BSSH were detected using oligonucleotide primer
airs LA45/AA821 and LA45/LA41, respectively (Favaro
nd Arrigo, 1997). RT-PCR was performed for 18 cycles to
etect each of these RNAs. b-Actin unspliced RNA was
etected by RT-PCR using previously described oligonu-
leotide primer pairs for 25 cycles (Arrigo et al., 1989;
avaro and Arrigo, 1997). GAPDH spliced RNA was de-
ected using oligonucleotide primer pairs GAPDH1, 59-
GTGAAGGTCGGAGTCAACG-39; and aGAPDH, 59-GTT-
AGGTCAATGAAGGGGTC-39. These oligonucleotides
ybridize to exon 2 and 3, respectively, of human GAPDH
NA. RT-PCR was performed for 17 cycles to detect this
NA. MHC class I spliced RNA was detected by RT-PCR
sing previously described oligonucleotide primer pairs
Favaro and Arrigo, 1997) for 20 cycles. The products
rom the RT-PCRs were resolved on 6% polyacrylamide
els. The bands were quantified using a Molecular Dy-
amics PhosphorKmager. The percentage of the specific
NA in each fraction was calculated and displayed using
ricket Graph. With the exception of the MHC class I
pliced RNA experiment (performed in duplicate), each
xperiment was performed in triplicate, and the error
ars represent standard deviation from the mean per-
entage.
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